Veradermics (MANE) Amortizatization of Intangibles (2025 - 2026)

Veradermics (MANE) reported Amortizatization of Intangibles of $73000.0 for Q1 2026, up 461.54% on a YoY basis from $13000.0 in Q1 2025, and up 461.54% quarter-over-quarter from $13000.0 in Q1 2025.

Veradermics (MANE) Amortizatization of Intangibles (2025 - 2026) Analysis & Trends

Veradermics has reported Amortizatization of Intangibles for 2 years, with the latest figure at $73000.0 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 13,267.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Veradermics 2.13 Bn 2.13 Bn - 73,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 73,000.00
Mar 31, 2026 73,000.00
Mar 31, 2025 13,000.00
Mar 31, 2025 13,000.00